Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Buchholz

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|August 21, 2020
Finding proteases that make cells go viralHector C Aguilar, David W Buchholz
Journal of Virology|July 21, 2021
Headless Henipaviral Receptor Binding Glycoproteins Reveal Fusion Modulation by the Head/Stalk Interface and Post-receptor Binding Contributions of the Head DomainYao Yu Yeo, David W Buchholz, Amandine Gamble, et al.
Journal of Virology|January 7, 2021
Roles of Cholesterol in Early and Late Steps of the Nipah Virus Membrane Fusion CascadeErik M Contreras, Gunner P Johnston, David W Buchholz, et al.
Mbio|December 5, 2019
Expression of 9-<i>O</i>- and 7,9-<i>O</i>-Acetyl Modified Sialic Acid in Cells and Their Effects on Influenza VirusesKaren N Barnard, Brian R Wasik, Justin R LaClair, et al.
Biorxiv : the Preprint Server for Biology|November 15, 2023
Migraine inhibitor olcegepant reduces weight loss and IL-6 release in SARS-CoV-2 infected older mice with neurological signsShafaqat M Rahman, David W Buchholz, Brian Imbiakha, et al.
Journal of Virology|May 30, 2024
Migraine inhibitor olcegepant reduces weight loss and IL-6 release in SARS-CoV-2-infected older mice with neurological signsShafaqat M Rahman, David W Buchholz, Brian Imbiakha, et al.
Viruses|September 28, 2021
Drivers and Distribution of Henipavirus-Induced Syncytia: What Do We Know?Amandine Gamble, Yao Yu Yeo, Aubrey A Butler, et al.
Science Advances|January 29, 2025
Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virusRichard A Adeleke, Julie Sahler, Annette Choi, et al.
Mbio|December 20, 2024
Functional assessment of the glycoproteins of a novel Hendra virus variant reveals contrasting fusogenic capacities of the receptor-binding and fusion glycoproteinsAndrew Z Ma, Yao Yu Yeo, Jean F Lee, et al.
Science Advances|January 3, 2024
Adaptive immune cells are necessary for SARS-CoV-2-induced pathologyBrian Imbiakha, Julie M Sahler, David W Buchholz, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|August 21, 2020
Finding proteases that make cells go viralHector C Aguilar, David W Buchholz
Journal of Virology|July 21, 2021
Headless Henipaviral Receptor Binding Glycoproteins Reveal Fusion Modulation by the Head/Stalk Interface and Post-receptor Binding Contributions of the Head DomainYao Yu Yeo, David W Buchholz, Amandine Gamble, et al.
Journal of Virology|January 7, 2021
Roles of Cholesterol in Early and Late Steps of the Nipah Virus Membrane Fusion CascadeErik M Contreras, Gunner P Johnston, David W Buchholz, et al.
Mbio|December 5, 2019
Expression of 9-<i>O</i>- and 7,9-<i>O</i>-Acetyl Modified Sialic Acid in Cells and Their Effects on Influenza VirusesKaren N Barnard, Brian R Wasik, Justin R LaClair, et al.
Biorxiv : the Preprint Server for Biology|November 15, 2023
Migraine inhibitor olcegepant reduces weight loss and IL-6 release in SARS-CoV-2 infected older mice with neurological signsShafaqat M Rahman, David W Buchholz, Brian Imbiakha, et al.
Journal of Virology|May 30, 2024
Migraine inhibitor olcegepant reduces weight loss and IL-6 release in SARS-CoV-2-infected older mice with neurological signsShafaqat M Rahman, David W Buchholz, Brian Imbiakha, et al.
Viruses|September 28, 2021
Drivers and Distribution of Henipavirus-Induced Syncytia: What Do We Know?Amandine Gamble, Yao Yu Yeo, Aubrey A Butler, et al.
Science Advances|January 29, 2025
Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virusRichard A Adeleke, Julie Sahler, Annette Choi, et al.
Mbio|December 20, 2024
Functional assessment of the glycoproteins of a novel Hendra virus variant reveals contrasting fusogenic capacities of the receptor-binding and fusion glycoproteinsAndrew Z Ma, Yao Yu Yeo, Jean F Lee, et al.
Science Advances|January 3, 2024
Adaptive immune cells are necessary for SARS-CoV-2-induced pathologyBrian Imbiakha, Julie M Sahler, David W Buchholz, et al.
Pageof 3